KEAP1 and non-small cell lung carcinoma: Our previously study revealed that KEAP1-mutant NSCLC is associated with higher TMB, and also found that the OS was prolonged in NSCLC patients receiving immunotherapy with wild-type KEAP1 compared with a mutant (6).